Target blood pressure and control status in Asia.


Journal

Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554

Informations de publication

Date de publication:
03 2020
Historique:
received: 31 08 2019
accepted: 10 09 2019
pubmed: 20 11 2019
medline: 27 5 2021
entrez: 20 11 2019
Statut: ppublish

Résumé

It is widely accepted that hypertension constitutes a significant cardiovascular risk factor and that treating high blood pressure (BP) effectively reduces cardiovascular risk. An important issue in Asia is not just the high prevalence of hypertension, particularly in some countries, but also the low level of awareness and treatment rates in many regions. The 2017 update of the American College of Cardiology/American Heart Association hypertension guidelines raised the question about which BP threshold should be used to diagnose and treat hypertension. Although there is a theoretical rationale for a stricter BP criterion in Asia given the ethnic-specific features of hypertension in the region, the majority of countries in Asia have retained a diagnostic BP threshold of ≥140/90 mm Hg. Although lowering thresholds might make theoretical sense, this would increase the prevalence of hypertension and also markedly reduce BP control rates. In addition, there are currently no data from robust randomized clinical trials of the benefits of the lower targets in preventing cardiovascular disease and reducing cardiovascular risk, particularly in high-risk patients and especially for Asian populations. There is also no defined home BP treatment target level for an office BP treatment target of 130/80 mm Hg. However, in this regard, in the interim, lifestyle modifications, including reducing body weight and salt intake, should form an important part of hypertension management strategies in Asia, while studies on treating at lower BP threshold level in Asians and getting to lower BP targets will be helpful to inform and optimize the management of hypertension in the region.

Identifiants

pubmed: 31742891
doi: 10.1111/jch.13714
pmc: PMC8029870
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

344-350

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

J Clin Hypertens (Greenwich). 2020 Mar;22(3):344-350
pubmed: 31742891
Hypertension. 2013 Feb;61(2):278-83
pubmed: 23248146
Circ J. 2017 Aug 25;81(9):1337-1345
pubmed: 28458378
Hypertens Res. 2008 Jul;31(7):1323-30
pubmed: 18957802
Curr Hypertens Rev. 2019;15(1):2-6
pubmed: 30729893
J Clin Hypertens (Greenwich). 2018 Mar;20(3):456-461
pubmed: 29450979
BMJ Open. 2013 Dec 23;3(12):e003733
pubmed: 24366578
Clin Hypertens. 2019 Aug 1;25:20
pubmed: 31388453
Hypertension. 2007 Aug;50(2):333-9
pubmed: 17576859
J Clin Hypertens (Greenwich). 2017 Nov;19(11):1192-1201
pubmed: 28815840
Arch Intern Med. 1993 Jan 25;153(2):154-83
pubmed: 8422206
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
J Clin Hypertens (Greenwich). 2018 Jan;20(1):33-38
pubmed: 29265725
Hypertens Res. 2019 Sep;42(9):1235-1481
pubmed: 31375757
Circulation. 2018 Nov 20;138(21):2312-2314
pubmed: 30571579
Hypertension. 2018 Oct;72(4):854-861
pubmed: 30354719
Hypertension. 2016 Jul;68(1):54-61
pubmed: 27160200
Arch Intern Med. 1988 May;148(5):1023-38
pubmed: 3365073
J Clin Hypertens (Greenwich). 2018 Dec;20(12):1686-1695
pubmed: 30444315
Circulation. 2018 Feb 6;137(6):546-548
pubmed: 29431657
J Am Coll Cardiol. 2018 May 15;71(19):2199-2269
pubmed: 29146533
Singapore Med J. 2018 Jan;59(1):17-27
pubmed: 29376186
Hypertension. 2007 Dec;50(6):991-7
pubmed: 17954719
J Hypertens. 2016 Nov;34(11):2187-98
pubmed: 27512964
Circulation. 2018 Feb 6;137(6):543-545
pubmed: 29431656
Circulation. 2008 Dec 16;118(25):2702-9
pubmed: 19106393
J Clin Hypertens (Greenwich). 2019 Feb;21(2):324-334
pubmed: 30525279
Acta Cardiol Sin. 2017 May;33(3):213-225
pubmed: 28559651
Hypertension. 2014 Nov;64(5):989-96
pubmed: 25156169
J Hypertens. 2014 Jun;32(6):1170-7
pubmed: 24621804
J Am Coll Cardiol. 2016 Apr 5;67(13):1519-1527
pubmed: 27150682
Hypertens Res. 2003 Jul;26(7):521-5
pubmed: 12924618
Hypertension. 2015 Oct;66(4):750-6
pubmed: 26303289
J Geriatr Cardiol. 2019 Mar;16(3):182-241
pubmed: 31080465
Int J Epidemiol. 2017 Apr 1;46(2):e1
pubmed: 25617647

Auteurs

Yook-Chin Chia (YC)

Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia.
Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Kazuomi Kario (K)

Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.

Yuda Turana (Y)

Department of Neurology, Faculty of Medicine, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.

Jennifer Nailes (J)

University of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines.

Jam Chin Tay (JC)

Department of General Medicine, Tan Tock Seng Hospital, Singapore City, Singapore.

Saulat Siddique (S)

Fatima Memorial Hospital, Lahore, Pakistan.

Sungha Park (S)

Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea.

Jinho Shin (J)

Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea.

Peera Buranakitjaroen (P)

Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Chen-Huan Chen (CH)

Department of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.

Romeo Divinagracia (R)

University of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines.

Satoshi Hoshide (S)

Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.

Huynh Van Minh (HV)

Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Vietnam.

Jorge Sison (J)

Department of Medicine, Medical Center Manila, Manila, Philippines.

Arieska Ann Soenarta (AA)

Department Cardiology and Vascular Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia.

Guru Prasad Sogunuru (GP)

MIOT International Hospital, Chennai, India.
College of Medical Sciences, Kathmandu University, Bharatpur, Nepal.

Apichard Sukonthasarn (A)

Bangkok Hospital Chiang Mai, Chiang Mai, Thailand.

Boon Wee Teo (BW)

Division of Nephrology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.

Narsingh Verma (N)

Department of Physiology, Faculty of Medicine, King George's Medical University, Lucknow, India.

Yuqing Zhang (Y)

Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Tzung-Dau Wang (TD)

Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.

Ji-Guang Wang (JG)

Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH